7GF Committee Information Form Please fill out the form below. This information will help us coordinate amongst the 7GF Committees and will facilitate abstract review. NamePlease list your name as you would like it listed on the 7th Global Forum website and any other Global Forum materials and information. First Middle Name or Initial (optional) Last Affiliation/InstitutionPlease list your affiliation/institution as you would like it listed on the 7th Global Forum website and other 7GF materials. CountryThis will be included with your name and affiliation on the 7th Global Forum website and other 7GF materials.AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland IslandsEmailPlease enter your preferred email for 7GF communications Assistant EmailIf there is someone we should copy on scheduling requests and calendar invitations, please include that email address here. This email will only be used for scheduling and not content-related emails. TracksPlease indicate the track that you are co-leading or for which you will be involved on a Track Committee. Once you select a track you will get a follow-up question on sub-tracks. Diversifying the TB Vaccine Pipeline Advancing Candidates through Clinical Trials Ensuring Public Health Impact Enabling Conditions for TB Vaccine Development Preparing for Implementation Diversifying the TB Vaccine Pipeline Sub-tracksFor which of these "Diversifying the TB Vaccine Pipeline" subtracks would you be able to provide expert abstract review? Please check all that apply. Mechanisms of biomarkers and protection Novel approaches to vaccine discovery Improved formulations and delivery platforms Human challenge model / Controlled human infection model Preclinical development Optimizing animal models Select AllAdvancing candidates through clinical trialsFor which of these "Advancing candidates through clinical trials" subtracks would you be able to provide expert abstract review? Please check all that apply. Clinical trials Trial site capacity Trial endpoints Correlates of protection Trial harmonization and design Improved preclinical and clinical readouts Community engagement Select AllHiddenEnsuring public health impact (old)For which of these "Ensuring public health" subtracks would you be able to provide expert review? Please check all that apply. Epidemiology Modeling impact Health system conditions for vaccine introduction Barriers and enablers of vaccine uptake Select AllEnsuring public health impact Demand assessments Delivery systems Vaccine value proposition Barriers and enablers of vaccine uptake Post-licensure studies Select AllPreparing for implementationFor which of these "Preparing for implementation" subtracks would you be able to provide abstract review? Please check all that apply. Policy pathways Procurement plans Implementation strategies Sustained financing strategies Engagement and communications strategies HiddenEnabling conditions for TB vaccine development (old)For which of these "Enabling conditions for TB vaccine development" subtracks would you be able to provide abstract review? Please check all that apply. Attract new investments Promote innovative financing Mechanisms for investment in early stages of development Promote and coordinate open science Create a supportive environment Overcome barriers to delivery and uptake Promote TB vaccine and research literacy Enabling conditions for TB vaccine development Funding Open science Political commitment Promote TB vaccine research literacy and advocacy Select All